BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24635914)

  • 1. Multicentric study on the beta-blocker use and relation with exacerbations in COPD.
    Puente-Maestu L; Calle M; Ortega-González A; Fuster A; González C; Márquez-Martín E; Marcos-Rodriguez PJ; Calero C; Rodríguez-Hermosa JL; Malo de Molina R; Aburto M; Sobradillo P; Alcázar B; Tirado-Conde G;
    Respir Med; 2014 May; 108(5):737-44. PubMed ID: 24635914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic obstructive pulmonary disease on inpatients with heart failure. GESAIC study results].
    Recio-Iglesias J; Grau-Amorós J; Formiga F; Camafort-Babkowski M; Trullàs-Vila JC; Rodríguez A;
    Med Clin (Barc); 2010 Apr; 134(10):427-32. PubMed ID: 20149399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-blocker prescription and chronic obstructive pulmonary disease].
    Ollivier R; Donal E; Delaval P; Daubert JC; Mabo P
    Ann Cardiol Angeiol (Paris); 2007 Nov; 56(5):231-6. PubMed ID: 17854758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Sirak TE; Jelic S; Le Jemtel TH
    J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of beta-blocker is associated with lower mortality in patients with coronary artery disease with or without COPD.
    Rezaei SS; Rinner C; Ratajczak P; Grossmann W; Gall W; Wolzt M
    Clin Respir J; 2018 Dec; 12(12):2627-2634. PubMed ID: 30276967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
    Matera MG; Martuscelli E; Cazzola M
    Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.
    Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carone M; Magni G; Ambrosino N; Tavazzi L;
    Eur J Prev Cardiol; 2017 Apr; 24(6):567-576. PubMed ID: 28067533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.
    Egred M; Shaw S; Mohammad B; Waitt P; Rodrigues E
    QJM; 2005 Jul; 98(7):493-7. PubMed ID: 15955798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study.
    Andrikopoulos G; Pastromas S; Kartalis A; Toli K; Mantas I; Tzeis S; Kyrpizidis C; Olympios C; Manolis AJ; Foussas S; Kranidis A; Pras A; Pipilis A; Chryssos D; Gotsis A; Trikas A; Richter D; Alexopoulos D; Parthenakis F; Theodorakis G; Konstantinides S; Vardas P
    Hellenic J Cardiol; 2012 Mar; 53(2):118-26. PubMed ID: 22484777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year stability of care dependency in patients with advanced chronic organ failure.
    Janssen DJ; Schols JM; Wouters EF; Spruit MA
    J Am Med Dir Assoc; 2014 Feb; 15(2):127-32. PubMed ID: 24314701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker under-use in COPD patients.
    Lim KP; Loughrey S; Musk M; Lavender M; Wrobel JP
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3041-3046. PubMed ID: 29089752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
    Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland.
    Hawkins NM; Jhund PS; Simpson CR; Petrie MC; Macdonald MR; Dunn FG; Macintyre K; McMurray JJ
    Eur J Heart Fail; 2010 Jan; 12(1):17-24. PubMed ID: 19951962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.